{"id":223040,"date":"2023-06-19T00:00:00","date_gmt":"2023-06-19T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041107-medtech-structural-heart-closure-devices-market-insights\/"},"modified":"2026-03-31T10:12:25","modified_gmt":"2026-03-31T10:12:25","slug":"47041107-medtech-structural-heart-closure-devices-market-insights-asia-pacific","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041107-medtech-structural-heart-closure-devices-market-insights-asia-pacific\/","title":{"rendered":"Structural Heart Closure Devices &#8211; Market Insights &#8211; Asia Pacific"},"content":{"rendered":"<p>Although the global <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> pandemic negatively impacted the Asia Pacific structural heart closure device market in 2020, strong prepandemic growth trends in the <abbr title=\"Patent Foramen Ovale\">PFO<\/abbr> and <abbr title=\"Left Atrial Appendage\">LAA<\/abbr> segments helped to sustain positive overall procedure volume and market growth for the year, and the market has subsequently shown strong recovery. Going forward, the market will continue to expand through 2032, supported by continued robust growth in the well-established Australian market, expanding evidence demonstrating the safety and efficacy of transcatheter and epicardial structural heart closure procedures, the introduction of new devices, and growing competition from and the strong presence of domestic manufacturers offering low-cost products in the large and expanding Chinese market.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the structural heart closure device market in Asia Pacific from 2019 through 2032.<\/p>\n<p class=\"question-statement\"><strong>The Asia Pacific structural heart closure device market will be impacted by the <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> pandemic in the early years of the forecast period.<\/strong><\/p>\n<p>How did the <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> pandemic impact the global structural heart closure device, and to what extent has it recovered?<\/p>\n<p>When is the structural heart closure market expected to revert to pre-pandemic growth?<\/p>\n<p><strong>The Asia Pacific market for structural heart closure devices will <span>grow moderately <\/span>through 2032.<\/strong><\/p>\n<p>What are upcoming developments in the structural heart closure device market?<\/p>\n<p>What ongoing clinical trials will impact the structural heart closure device market?<\/p>\n<p>How are clinical developments across the globe impacting the Asia Pacific structural heart closure device market?<\/p>\n<p>Which new devices have been launched over the past year and are expected to launch in the Asia Pacific market?<\/p>\n<p><b>The <abbr title=\"Left Atrial Appendage\">LAA<\/abbr> closure device segment represents a significant market opportunity for manufacturers in the <strong>structural heart closure device<\/strong> space.<\/b><\/p>\n<p>What strategies will <abbr title=\"Multinational Corporation\">MNC<\/abbr>s adopt to compete with the domestic players in the Asia Pacific market?<\/p>\n<p>Who are the new players in the <abbr title=\"Left Atrial Appendage\">LAA<\/abbr> closure device market?<\/p>\n<p>How are the domestic players able to maintain their position in the Asia Pacific market?<\/p>\n","protected":false},"template":"","class_list":["post-223040","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-structural-heart-closure-devices","medtech-geography-asia-pacific","medtech-date-976"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/223040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/223040\/revisions"}],"predecessor-version":[{"id":281648,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/223040\/revisions\/281648"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=223040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}